Coordinator, Emerging Therapeutics Strategy Program
Jennifer Day, PharmD is with Kaiser Permanente National Drug Information Services and serves as Coordinator of the Emerging Therapeutics Strategy Program for Kaiser Permanente National Pharmacy. Dr. Day’s areas of expertise include drug information and analysis of clinical trial evidence, development of evidence-based guidelines, strategic planning for the use of biologics and emerging pharmaceuticals, biosimilars and specialty pharmacy oversight, and pharmaceutical pipeline forecasting. She plays a key role in facilitating the development of innovative treatment pathways through collaboration with physicians and pharmacists in the various Kaiser Permanente regions to proactively evaluate and prepare for optimal use of new and pipeline emerging therapeutics. Dr. Day earned her Doctor of Pharmacy from the University of Southern California and completed a pharmacy practice residency at San Francisco VA Health Care System.
Tuesday, March 26
4:15 PM – 5:30 PM